KLK3 and prostate carcinoma: Historically, these men would undergo PSA testing generally every six months, followed by random 12-core transrectal ultrasound biopsies, usually one to two years after diagnosis, and further biopsies performed when clinical suspicion of prostate cancer increased, generally due to rising PSA [2,3,34].